NYU Langone Health on Monday named Dr. Alec Kimmelman as its next chief executive officer and dean of New York University’s Grossman School of Medicine — concluding a comprehensive nationwide search.
Kimmelman, who has been leading NYU Langone’s Laura and Isaac Perlmutter Cancer Center since 2023, will officially step into his new role on Sep. 1, succeeding Dr. Robert Grossman, who is retiring after 18 years at the helm of the hospital.
“I am humbled and excited to be the next CEO and Dean of NYU Langone and appreciate the confidence the Board of Trustees and the search committee have placed in me,” Kimmelman said.
The announcement by NYU Langone’s Board of Trustees was praised by board chairman Kenneth Langone, who was co-chair of the search committee.
“We are excited to name Dr. Kimmelman to this position given his extraordinary talent, leadership experience, and strong character,” Langone, the billionaire businessman and philanthropist who made his fortune as co-founder of Home Depot, said in a statement.
Langone, a graduate of NYU’s Stern School of Business, emphasized confidence in Kimmelman’s ability to “build on Bob’s legacy and lead our institution into its next phase of innovation and impact.”
Kimmelman highlighted his commitment to maintaining NYU Langone’s excellence in patient care, education, and scientific research — building on the remarkable progress made under Grossman.
Grossman commended his successor’s accomplishments, particularly his groundbreaking research in molecular oncology.
“Throughout his career at NYU Langone, most recently leading Perlmutter Cancer Center, Dr. Kimmelman has further established our integrated academic health system as a leader in research and treatment,” Grossman said.
Incoming board chair Fiona Druckenmiller noted her excitement about collaborating with Kimmelman.
“Ken and Dr. Grossman shared a bold vision and an amazing partnership that made NYU Langone what it is today. I am excited to cultivate a similar working relationship with Dr. Kimmelman,” she stated.
Under Grossman’s leadership, NYU Langone evolved from a regional hospital into a nationally recognized academic healthcare system — achieving annual revenues of $14.2 billion and expanding significantly.
The network recently opened a hospital in Suffolk County and began initiating plans for a comprehensive outpatient center in West Palm Beach, Fla.
However, a proposed $3 billion plan to build a cutting-edge NYU Langone medical center at Nassau Community College has been put on hold indefinitely due to “external factors that have presented issues that may prove to be too burdensome to overcome,” Nassau County Executive Bruce Blakeman said last week.
The 89-year-old Langone has donated at least $400 million to NYU Langone Health, including $100 million in 2008, another $100 million in 2018 to support tuition-free medical education and $200 million in 2023 to fund scholarships at NYU Long Island School of Medicine.
His broader philanthropy also includes $10 million to NYU’s MBA program and over $5 million to the Animal Medical Center in New York.
NYU Langone Health has earned the top ranking from Vizient, Inc. among comprehensive academic medical centers nationwide for the third consecutive year.
It also achieved significant recognition in national hospital rankings.
In US News & World Report’s 2024-2025 “Best Hospitals” rankings, NYU Langone was placed on the Honor Roll of top 20 hospitals nationwide.
Notably, it secured the No. 1 position in both neurology and neurosurgery for the third consecutive year, as well as in pulmonology and lung surgery.
The institution also ranked second nationally in cardiology, heart surgery and vascular surgery while achieving top-five standings in several other specialties, including urology, geriatrics, orthopedics, rehabilitation, diabetes and endocrinology and gastroenterology and GI surgery.
[Notigroup Newsroom in collaboration with other media outlets, with information from the following sources]
